2024 was a pivotal year for the Company, in which we met several critical milestones. In particular, we made significant progress towards entering the rapidly growing U.S. drug screening market. With ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...

The first music festival to take part in a state's pill-testing trial has been named but doubts remain about how effective ...

Intelligent Bio Solutions (INBS) issued a letter to shareholders from Harry Simeonidis, President and CEO, reflecting on a year of growth in ...

We find using G•U wobble base pairs is a universally applicable strategy to improve editing ... we developed an ex vivo drug screening method that combines imaging, deep learning and multiomics ...

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative anti-aging strategy.

Police forces currently have the power to test someone arrested for particular offences, on arrest or after they are charged, ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

This important manuscript proposes a new strategy for the identification of new mechanisms of drug resistance based on SAturated Transposon Analysis in Yeast (SATAY), a powerful transposon sequencing ...

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike. Following a turbulent period marked by Brexit and the ...

Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...